21 December 2023
The Kosinski Group at EMBL Hamburg collaborated with other groups in Hamburg to reveal critical steps in Lassa virus ribonucleoparticle assembly and recruitment, and the crucial role played by RNA in in the Lassa virus life cycle.
5 July 2023
Science, Technology and innovation
Enabling researchers worldwide to share and analyse pathogen data generated across the world
20 December 2022
Updates from data resources
The first cohort study linking data across categories was recently added on the Pathogens Portal Cohort Browser and is also accessible from the BioSamples browser. This pilot study comes from Erasmus Medical Centre through the ReCoDID project, one of the COVID-19 Data Platform supporting…
23 March 2022
Zamin Iqbal and his team are working with researchers all over the globe to help put a stop to Tuberculosis
18 November 2021
The upcoming 22nd EMBL Science & Society Conference will explore the One Health approach, which advocates for greater cross-sectoral collaboration and communication across the human-animal-environment interface.
21 October 2021
The BY-COVID project aims to make infectious disease data, including COVID-19, openly available to everyone.
15 October 2021
The Graham and Crump groups at the University of Cambridge and the Svergun Group at EMBL Hamburg have discovered a mechanism by which the herpes simplex virus takes control of the molecular machinery of human cells. Their work reveals how a dedicated viral protein hijacks key host proteins, forcing…
7 July 2021
Research in the Typas group uncovers new details of the strategies Salmonella uses to survive in infected cells.
25 June 2021
EMBL Hamburg’s Wilmanns and Kosinski groups have determined the detailed structure of a bacterial protein complex critical for tuberculosis infection.
25 May 2021
Picture of the week
The Bernabeu Group aims to increase our knowledge of cerebral malaria, using in vitro engineered networks of human blood vessels and brain cells.
21 May 2021
EMBL scientists support research on malaria by providing freely available data resources and using innovative experimental approaches. Our Course and Conference Office facilitates the exchange of knowledge in the field by hosting the annual BioMalPar conference.
20 April 2021
EMBL and Portugal are bringing together leading scientists to highlight the role of fundamental research in tackling infectious diseases.
17 February 2021
Researchers from EMBL and Heidelberg University Hospital combine high-resolution imaging to observe the infection process in cell nuclei, opening the door for new therapeutics.
19 January 2021
Freshwater sports can cause waterborne infections, but real-time DNA sequencing could help.
2 December 2020
Members of the EMBL community are working to improve our understanding of the parasites that cause malaria and sleeping sickness
13 October 2020
A group of scientists led by EMBL Hamburg’s Christian Löw provide insights into the molecular structure of proteins involved in the gliding movements through which the parasites causing malaria and toxoplasmosis invade human cells.
17 July 2020
European collaboration receives funding to explore risks and impact of future infectious disease outbreaks.
8 June 2020
Scientists including members of EMBL’s Typas group have investigated how immune cells called macrophages respond to infection by the intracellular pathogen Salmonella enterica. They discovered that Salmonella causes newly produced cathepsins to accumulate in the nuclei of infected cells to…
28 April 2020
Scientists at EMBL Hamburg and Karolinska Institutet Stockholm aim to find synthetic antibodies – known as nanobodies – that bind a surface protein of the novel SARS-CoV-2 coronavirus. Nanobodies could prevent the virus from entering human cells and causing COVID-19.
24 April 2020
In March 2020, planes were grounded, streets went quiet, and our lives changed forever. But while the world came to a halt, many scientists were ramping up their efforts to understand the new virus.
20 April 2020
The new collaborative space will help scientists, public health and healthcare professionals around the world to fight the coronavirus pandemic.
26 September 2019
From 27–30 September, Tara will be docked in the port of Marseille, France’s second largest city.
4 May 2008
Influenza is currently a grave concern for governments and health organisations around the world. Now one of the tactics used by influenza virus to take over the machinery of infected cells has been laid bare by structural biologists at the EMBL, the joint Unit of Virus Host-Cell Interaction of…
22 June 2007
A new mechanism to attack hard-to-treat fungal infections has been revealed by scientists from the biotech company Anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory [EMBL] outstation in Grenoble, France. In the current issue of Science they describe…
25 February 2007
In 1918, 50 million people died during a worldwide influenza pandemic caused by mutation of a bird-specific strain of the influenza virus. Recently H5N1, another highly infectious avian strain has caused outbreaks of bird flu around the world. There is great concern that this virus might also…
12 February 2007
Liver cancer is one of the deadliest cancers worldwide; every year sees more than 400,000 new cases, and most of the victims die in less than one year. Despite extensive research, the underlying molecular mechanisms of the disease are poorly understood. A new study by researchers from the Mouse…
5 April 2006
Today the network of excellence for Biology and Pathology of the Malaria Parasite (BioMalPar), will bring together the world’s elite in the field of Malaria research at the European Molecular Biology Laboratory (EMBL) in Heidelberg. At the second annual BioMalPar conference, organised jointly…
No matching posts found